Understanding Optimizing Dosing Regimen In Multiple Myeloma
Exploring Optimizing Dosing Regimen In Multiple Myeloma reveals several interesting facts. This video is part of the HMP Education content archive and may include previously accredited educational material. While this ...
Key Takeaways about Optimizing Dosing Regimen In Multiple Myeloma
- Dr Elizabeth O'Donnell speaks to ecancer about the real-world effectiveness of immunoglobulin replacement
- Jonathan Kaufman, MD, Emory University School of Medicine, Atlanta, GA, shares his insights into determining the optimal ...
- Luciano Costa, MD, PhD, UAB School of Medicine, Birmingham, AL, discusses the advantages of alnuctamab, a BCMAxCD3 ...
- Enrique Ocio, MD, PhD, Marquis of Valdecilla University Hospital, Santander, Spain, discusses practical considerations for the ...
- Autologous hematopoietic stem cell transplantation (autoHSCT) is the current standard of care (SOC) for newly diagnosed ...
Detailed Analysis of Optimizing Dosing Regimen In Multiple Myeloma
Nisha Joseph, MD, Winship Cancer Institute, Emory University, Atlanta, GA, discusses the results of a Phase II Karthik Ramasamy, MBBS, MRCP, FRCPath, PhD, Oxford University Hospitals NHS Foundation Trust, Oxford, UK, shares insights ... Clark DuMontier, MD, MPH, VA Boston Healthcare System, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, ...
Rafael Fonseca, MD, Mayo Clinic, Phoenix, AZ, discusses the findings of a study investigating optimal treatment sequencing in ...
Stay tuned for more updates related to Optimizing Dosing Regimen In Multiple Myeloma.